insights_auto
Why is TMCI down 3.12%?
Dive Deeperchevron_right
TMCI:NASDAQ
Treace Medical Concepts, Inc
$4.34
arrow_downward
-3.12%(-0.14) 1D
Oct 6, 10:56:14 AM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for TMCI...
Open
$4.53
High
$4.53
Low
$4.33
Mkt. cap
275.94M
Avg. vol.
235.91K
Volume
20.98K
52-wk high
$7.08
52-wk low
$1.17
EPS
-$0.93
Beta
1.48
Shares outstanding
65.04M
No. of employees
450
Open
$4.53
High
$4.53
Low
$4.33
Mkt. cap
275.94M
Avg. vol.
235.91K
Volume
20.98K
52-wk high
$7.08
52-wk low
$1.17
EPS
-$0.93
Beta
1.48
Shares outstanding
65.04M
No. of employees
450
News stories
From web sources and news partners
The Lufkin Daily News
·
45 minutes ago
FILE PHOTO: Traders react to the Fed rate announcement on the floor of the NYSE in New York
Yahoo Finance
·
46 minutes ago
The 3 tech stocks accounting for over 20% of the S&P 500
The Daily Tribune News
·
31 minutes ago
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Option Care Health, Inc. (Nasdaq – OPCH), Lantheus Holdings Inc. (Nasdaq – LNTH), MarketAxess Holdings Inc. (Nasdaq – MKTX), Sangoma Technologies C
CNBC
·
1 hour ago
Opening Bell: October 6, 2026
Profile
Treace Medical Concepts, Inc. is a medical device company, headquartered in Ponte Vedra Beach, Florida, specializing in the design, manufacture, and marketing of foot and ankle surgical devices and biologics. Lapiplasty, Treace’s novel primary surgical product, advanced the treatment of bunions, surgically correcting the metatarsal bone, for the first time, in all three dimensions.
In March 2021, Treace announced its intent to launch an initial public offering. Trading on the Nasdaq under the ticker symbol “TMCI”, Treace opened its IPO in April 2021. Wikipedia
About Treace Medical Concepts, Inc